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Foi desenvolvida uma nova técnica que possibilita o monitoramento da liberação de fármacos 
encapsulados, sem a separação das partículas do meio de liberação, usando espectroscopia de 
refletância difusa. Foram realizados estudos de liberação do cloro(5,10,15,20-tetrafenilporfirinato) 
de índio(III) (InTPP) a partir de micro e nanoesferas do copolímero do ácido lático-co-glicólico 
(PLGA). A liberação do InTPP foi bifásica, com uma liberação rápida inicial seguida por uma 
segunda fase mais lenta de liberação. Modelos matemáticos aplicados aos perfis de liberação 
mostraram que a liberação do InTPP a partir das nanoesferas foi controlada por difusão, o que 
é esperado para uma substância homogeneamente dispersa dentro da esfera. Contudo, devido a 
larga distribuição de tamanho das microesferas carregadas com InTPP, os perfis de liberação foram 
irregulares, dificultando o adequado ajuste dos nossos modelos matemáticos. Análise confocal 
das micropartículas mostrou que o InTPP aparenta ser homogeneamente distribuído dentro das 
microesferas e nenhuma distribuição preferencial do InTPP foi observada em direção ao interior 
ou a zona superficial da esfera. 
A new technique using diffuse reflectance spectroscopy was developed that enables the 
monitoring of encapsulated drug release without particle separation from the assayed medium. 
Studies of chloro(5,10,15,20-tetraphenylporphyrinato)indium(III) (InTPP) release from 
microspheres and nanospheres of poly(lactide-co-glycolide) (PLGA) were performed using this 
new technique. The release of InTPP was biphasic, with an initial fast release followed by a second 
slower release. Mathematical models applied to the release profiles showed that the release of 
InTPP from the nanospheres was controlled by diffusion, which is to be expected for a substance 
homogeneously dispersed within the spheres. However, due to the large size distribution of the 
microspheres loaded with InTPP, the release profiles were irregular, hampering an adequate fit 
to mathematical models. Confocal analysis of microparticles showed that the InTPP appeared to 
be homogenously distributed within the microspheres and no preferential distribution of InTPP 
towards the interior or towards the surface of the spheres was observed. 
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Introduction
Tetraphenylporphyrins are interesting compounds 
for  photodynamic therapy (PDT),  s ince their 
photophysical properties favor the production of 
singlet oxygen.1-4 The presence of In(III) in the core 
of the photosensitizer structure enhances the in vitro 
and in vivo photodynamic efficacy,5,6 and recent 
studies carried out in our laboratory have shown that 
chloro(5,10,15,20-tetraphenylporphyrinato)indium(III) 
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(InTPP) is an interesting photosensitizer for PDT 
because InTPP was 1.37-1.5 times more effective in 
the photooxidation of red blood cells than Photofrin®,1 
a commercial photosensitizer. In in vitro studies InTPP-
loaded nanoparticles of poly(lactide-co-glycolide) 
(PLGA) were more efficient than free InTPP in inducing 
human prostate carcinoma cell death, predominantly by 
apoptosis, showing an effective strategy for application 
of this very hydrophobic photosensitizer in future studies 
of PDT.7 
Investigations of drug release often provide important 
information about the internal structure of the carrier 
and the drug-carrier physicochemical relationships 
for developing successful formulations. However, an 
appropriately designed in vitro release study is often 
difficult to conduct because of a number of technical 
problems.8 In most techniques the monitoring of the 
drug release profile is performed by a physical separation 
of the colloidal drug carrier from the release medium 
to discriminate the unreleased and released drug. The 
results obtained using these methods reflect complex 
kinetics of several simultaneous processes, and therefore 
their interpretation may be highly misleading.9 The 
objective of the present study was to develop a new 
technique that enables the monitoring of drug release, 
without prior separation of the spheres from the assayed 
medium, using diffuse reflectance spectroscopy.10 The 
centrifugation step necessary to separate the spheres from 
the liquid phase to quantify the release of encapsulated 
drug at different intervals of time was eliminated by the 
novel technique.
InTPP was used as a hydrophobic drug model to 
study drug release from microspheres and nanospheres 
of PLGA using the new technique. Mechanistic 
mathematical models were applied to the release 
profiles to indicate if the encapsulated InTPP was in 
the polymeric matrix in the form of aggregates or was 
present as a homogenous molecular dispersion. Since the 
size and shape of the spheres, the drug loading and the 
drug distribution inside the polymeric spheres can are 
affect the rate of drug release, spheres were characterized 
with respect to size, surface morphology, entrapment 
efficiency and spatial distribution of InTPP within 
the spheres using scattering electronic microscopy, a 
colorimetric method and confocal microscopy.11 Some 
papers have shown that the residual PVA on the particle 
surface can influence properties such as particles size 
distribution, zeta potential and drug release profile.12,13 
Therefore, we decided to quantify the residual emulsifier 
on the sphere surfaces and to evaluate the influence of 





(degree of purity > 95%) was purchased from Frontier 
Scientific Inc. (Logan, UT, USA). Hydrochloric acid, 
chloroform, 50:50 poly(lactide-co-glycolide) (average 
molar mass (M
w
) = 50,000-70,000 g mol-1), poly(vinyl 
alcohol) (PVA) (M
w
 = 13,000-23,000 g mol-1, degree of 
hydrolysis = 89%) and sodium hydroxide were purchased 
from the Sigma Chemical Company (St. Louis, MO, USA). 
Isobutyl alcohol, tetrahydrofuran (THF) and polystyrene 
were obtained from Merck (Whitehouse Station, NJ, USA). 
Iodine, potassium iodide and boric acid were purchased 
from Acros Organics (New Jersey, NJ, USA). The water 
used throughout the experiments was first bi-distilled 
and then deionized in a Milli-Q ultra-purification system 
(Millipore, Bedford, MA, USA). All other chemicals 
were of analytical grade and were used without further 
purification.
Preparation of PLGA spheres 
The PLGA spheres were prepared using a modified 
emulsion/evaporation technique.7,14 Typically, 50 mg of 
PLGA and 0.30 mg of InTPP were dissolved in a mixture of 
chloroform and ethanol (95:5 v/v, respectively). The organic 
phase was added slowly to an aqueous solution of PVA (2%, 
m/v) and ethanol (11%, v/v), which was homogenized for 
30 min at 14,000 rpm to obtain nanospheres (UltraTurrax 
T18, IKA, Wilmington, NC, USA) or at 1200 rpm to obtain 
microspheres (Model 713D, Fisatom, São Paulo, SP, Brazil). 
Each resulting emulsion was subjected to magnetic stirring 
for a period of 24 h to evaporate the CHCl
3
. The nanospheres 
obtained after the evaporation period were recovered by 
centrifugation at 20,400 × g for a period of 20 min at 10 °C 
(Beckman J2-21, Beckman Instruments, Fullerton, CA, USA), 
and washed six times with water to remove the excess PVA and 
nonincorporated InTPP. The same procedure was performed 
to recover the microspheres. Use of a single washing step 
produced spheres containing 2.7 times more residual PVA, on 
average. Studies have shown that cryoprotectors such as sugars 
prevent the aggregation of the particles during lyophilization.15 
Then, particle suspensions containing trehalose as a 
cryoprotector agent (trehalose mass: PLGA mass = 1:1) were 
frozen in liquid nitrogen and freeze-dried at a pressure of 
0.001 mbar in a Labcongo lyophilizer, model Freezone 
4.5 (Kansas, MO, USA) for 2 days. Three independent 
formulations of both microspheres and nanospheres were 
prepared using the above method.
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Particle morphology and mean size
The particle morphologies were analyzed in accordance 
with Silva et al.7 Typically, approximately 1 to 2 mg of 
lyophilized spheres were dispersed in deionized water and a 
droplet of this aqueous suspension was placed directly onto a 
metallic stub. Samples air dried over the stub were coated with 
a thin layer of gold with a Bal-Tec coater MED 020 (Balzers, 
Liechtenstein) using a current of 30 mA and a pressure of 
6.7 Pa for a period of 160 min. The images obtained from 
Scanning Electron Microscopy (SEM) were analyzed using 
an image analysis software package (UTHSCSA ImageTool 
3.0 UTHSCSA, San Antonio, TX, USA) combined with 
Origin 6.0 (OriginLab Corp., Northampton, MA, USA) to 
obtain the particle size distribution of the microspheres and 
nanospheres present in the lyophilized formulations. Five 
images of each replicate, from different points on the stub, 
were selected to determinate the particle size. An average was 
obtained from approximately 700 spheres for each replicate. 
The values are the mean of three replicate samples.
Zeta potential
The zeta potential of the spheres was measured from 
their electrophoretic mobility using a Zetasizer 3000 HAS 
(Malvern Instruments, Worcestershire, UK), employing 
a quartz capillary cell containing a pair of palladium 
electrodes, as previously reported by Vandervoort and 
Ludwig16 and Zhang and Feng.17 About 3 mg of the freeze-
dried microspheres or nanospheres were dispersed in 10 mL 
of fresh deionized water without surfactant, followed by 
sonication for a period of 1 min. We monitored the pH 
(5.2 ± 0.4) and the conductivity (0.50 ± 0.03 mS cm-1) of 
Milli-Q water and no significant variation was observed 
during the experiment. This dispersion was injected into 
the capillary of the Zetasizer 3000 and the zeta potential 
was measured ten times. The mean zeta potential values 
for three replicates were calculated.
Particle recovery and entrapment efficiency
Determinations of particle recovery and entrapment 
efficiency were performed as described previously.7 The 
experiments were carried out in triplicate and the particle 
recovery was calculated using equation (1).
 (1)
The InTPP incorporation efficiency was expressed using 
equations (2) and (3). 
 (2)
 (3)
Typically, an amount of lyophilized spheres 
(2.0 mg) loaded with InTPP was dissolved in 1.0 mL of 
chloroform (a common solvent for PLGA and InTPP). 
The InTPP in the solution was quantified using UV-vis 
spectroscopy (Hewlett Packard 8453A-Diode Array 
Spectrophotometer, Avondale, PA, USA) at 425 nm using 
an analytical curve obtained from ten different InTPP 
concentrations. The absorbance measurements established 
no interference from the PLGA polymer under the same 
conditions. The following validation parameters were 
calculated for this method: linearity = 0.3-2.5 mmol L-1, 
intraday variability = 1.4%, interday variability = 2.5%, 
l imi t  of  de tec t ion =  0 .08 mmol  L -1,  l imi t  of 
quantification = 0.3 mmol L-1, accuracy = 94.4 ± 3.6% 
with significance of 99%.
Determination of residual PVA
PVA tends to be adsorbed on the surface of a sphere 
through the hydrophobic part of vinyl acetate, which 
tends to anchor the polymer on the aqueous/organic 
interface formed during the emulsification process.12,18 
After coacervation of phases the methyl groups of 
vinyl acetate are localized in the solid matrix of the 
sphere and the hydroxyl groups of PVA are exposed to 
aqueous phase. The amount of residual PVA associated 
with the spheres was determined using a colorimetric 
method based on the formation of a colored complex 
between the hydroxyl groups of PVA and iodine 
molecules.19 Typically, 3 mg of spheres freeze-dried 
without trehalose were treated with 2 mL of 0.5 mol L-1 
NaOH for 15 min at 60 °C. Each sample was neutralized 
with 900 mL of 1 mol L-1 HCl and the volume was 
adjusted to 5 mL with deionized water. To each sample, 
3 mL of a 0.65 mol L-1 solution of boric acid, 0.5 mL 
of a solution of I
2
/KI (0.05 mol L-1/0.15 mol L-1), 
and 1.5 mL of deionized water were added. Finally, 
the absorbance of the samples was measured at 
664 nm after incubating for 15 min. A standard plot 
for PVA was prepared under identical conditions. 
All the determinations were performed in triplicate. 
The following validation parameters were calculated 
for this method: linearity = 1.3-25 mg L-1, intraday 
variability = 3.9%, interday variability = 5.2%, limit of 
detection = 0.4 mg L-1, limit of quantification = 0.3 mg L-1, 
accuracy = 92.8 ± 4.5% with significance of 99%. 
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In situ InTPP release
A mass of 1.2 mg of lyophilized nanospheres or 0.6 mg 
of lyophilized microspheres was suspended in 2.0 mL of 
isobutyl alcohol at 27 °C in a closed quartz cuvette. This 
solvent was chosen because it is a solvent that dissolves 
InTPP, but not PLGA. The solubility of InTPP in isobutyl 
alcohol was determined at 27 °C to be 97 ± 7 mmol L-1 (data 
not shown). The total InTPP concentration (2.0 mmol L-1) 
found in the lyophilized spheres was 49 times smaller than 
the solubility of InTPP in isobutyl alcohol, securing sink 
conditions to the experiment and adherence to Beer’s law. 
Our experiments were performed in an organic solution to 
monitor the release of InTPP from spheres due to diffusion 
of the compound from the spheres without invoking any 
chemical degradation of the spheres. Therefore, the purpose 
of these experiments did not simulate drug release in a 
cellular environment. The cuvette was kept in the dark 
to avoid photodegradation of the photosensitizer. The 
particles were maintained dispersed in the release medium 
by magnetic stirring throughout the experiment. The 
absorbance spectrum of the suspension at predetermined 
time intervals was measured at a wavelength of 421 nm 
using diffuse reflectance spectroscopy (DRS) (Varian 
Cary-5 UV-Vis-Nir, Palo Alto, CA, USA) without any 
prior separation of the spheres from the release medium.10 
The InTPP release was monitored until the percentage of 
release was 70% or greater. The DRS technique allowed 
us to eliminate centrifugation step before quantifying the 
drug released at various time intervals to the medium. The 
conditions that we have used with this technique were: 
ratio of lyophilized particles per volume of release medium 
≤ 0.65 g L-1, photosensitizer solubility in the aqueous 
release medium < 0.3 mmol L-1, absorbance wavelength 
range from 200 nm to 800 nm and photosensitizer molar 
mass from 580 to 680 g mol-1. A patent describing this 
procedure has been deposited in Brazil.10 The cuvette was 
placed at the front slit of the integrating sphere and a solid 
standard of poly(tetrafluoroethylene) was placed at the 
back slit. The spectrum obtained from a standard blank 
of poly(tetrafluoroethylene) and a cuvette containing only 
isobutyl alcohol was used to correct for any nonassigned 
signals. To identify if the monitored absorbance was due to 
InTPP released to the isobutyl alcohol or to InTPP dispersed 
in the spheres, independent experiments were performed 
at short (1.5 h), medium (78.3 h), and long release times 
(483.5 h). After these predetermined release times, each 
suspension was centrifuged (30 min, 23,708 × g) to separate 
the supernatant (released InTPP + isobutyl alcohol) and the 
microspheres or nanospheres. The absorbance spectrum of 
the supernatant was measured at 421 nm using DRS, and 
the profile and intensity of the supernatant spectrum was 
compared to the suspension spectrum. The spheres were 
dissolved in chloroform and the InTPP absorbance was 
measured at 425 nm. Analytical curves of InTPP in isobutyl 
alcohol (421 nm) and chloroform (425 nm) were used to 
quantify the amount of InTPP in the release medium and 
dispersed in the spheres, respectively. This release study was 
performed in triplicate. The following validation parameters 
were calculated for this method of quantification: 
linearity = 0.3-1.2 mmol L-1, intraday variability = 1.5%, 
interday variability = 2.1%, limit of detection = 0.1 mmol L-1, 
limit of quantification = 0.3 mmol L-1, accuracy = 98.1 ± 1.6% 
with significance of 99%. 
Mathematical models applied to the release profiles
Three mathematical models were applied to the release 
profiles from the microspheres and the nanospheres loaded 
with InTPP to evaluate if the encapsulated InTPP was in 
the polymer matrix as a homogenous molecular dispersion 
(Jo’s model and Peppas’s model) or as a solid agglomerate 
(Polakovic’s model). Jo’s model assumes that releases are 
governed solely by diffusion, a mass transfer process that 
can be quantified using Fick’s second law,20 which has the 
following form for spheres:
 (4)
where c is the local substance concentration at time, t, at 
distance, r, from the sphere’s center, and D is the diffusion 
coefficient of the substance in the matrix. Assuming that 
the substance is uniformly distributed inside the delivery 
system, a perfect sink condition is maintained for the 
experiment and also assuming that a standard condition 
of symmetry from the center of the spherical particle is 
present, the following analytical solution of Fick’s second 
law of diffusion related by Jo et al.20 can be used to describe 




 and M∞ are the total amount of InTPP in the 





) represents the equilibrium ratio of released and 
retained InTPP , V is the bulk liquid volume, V
t
 is the total 
volume of the spheres, K
p
 = c
i∞/cb∞ is the partition coefficient 
characterized by the ratio of intraparticle and bulk liquid 
InTPP concentrations in thermodynamic equilibrium, and 
q
n
 is the nonzero positive root of the transcendent equation,
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 (6)
Since we could not disregard the possible existence 
of “nanopores” in the spheres, the term D represents the 
apparent diffusivity, taking into account drug transfer 
through the polymer itself, as well as possible drug transfer 
through any “nanopores” filled with isobutyl alcohol. 





 and M¥ are the total amount of InTPP in the 
sphere after time t, and after infinite time, respectively, k 
is a constant that incorporates the properties of the matrix 
of the sphere and of the InTPP, and n is the diffusional 
exponent, which is indicative of the transport mechanism. 
Equation (7) was used to characterize the first 60% of the 
release behavior of InTPP from the polymer spheres. A 




1/2) from a one-dimensional matrix.22 
For spheres, when corrected for the geometry of the device 
(microparticles or nanoparticles), the diffusional exponent 
changes to a value of 0.43 and Fickian diffusion occurs in 
a spherical monolithic matrix. 
Polakovic’s mathematical model is a dissolution 
mathematical model that is expected to fit a drug release 
profile when a solid agglomerate of a drug is present in 
the polymer matrix.23 Drug dissolution is not a mechanism 
by which a drug is transported out of a polymer matrix, 
since this occurs by subsequent drug diffusion. However, 
dissolution would affect the rate of diffusional flux from 
the polymer spheres. Therefore, the dissolution rate of the 
drug is often the rate-determining step when absorption 
rates are faster than dissolution rates (e.g., for steroids). 
If this situation occurs, then a curative effect of the drug 
cannot be expected, owing to its limited residence time at 
the absorption site. The dissolution model of Polakovic et 
al.23 was also applied to the data of InTPP release to evaluate 







 are the amount of InTPP in the 
bulk liquid and the initial amount of intraparticle InTPP, 
respectively, k is the apparent dissolution rate constant, and 
a and K
p
 have the same meaning as in the first diffusion 
model. Equations (5), (7) and (8) were fitted to the release 
profile of the InTPP loaded-nanospheres and microspheres 
using the software Origin 7.5. The correlation coefficient 
for each fitted mathematical model and the values of D, 
n, and k, respectively, for the equation (5), (7) and (8), 
provided by the software were analyzed. 
Confocal microscopy
The distribution of the InTPP within PLGA microspheres 
was determined using confocal microscopy. A small amount 
(2 mg) of lyophilized microspheres was redispersed in 
1.0 mL of deionized water and a droplet of this suspension 
was spread onto a microscope slide. Samples were air-
dried and the slide covered with a thin glass plate. The 
microspheres were visualized using a Zeiss Confocal LSM 
510 microscope equipped with an argon-krypton laser 
(l
ex
 = 488 nm) (Carl Zeiss Microimaging, Inc., Thornwood, 
NY, USA). The fluorescent emission of InTPP between 
505 and 550 nm was selected using a BP505–550 band-
pass filter (Carl Zeiss Microimaging, Inc.). An optical 
cross section was taken using a gradual depth increase 
of 0.6 mm to determine the distribution of the InTPP in 
the microspheres. Unloaded PLGA-spheres were also 
analyzed to confirm that the fluorescence observed from the 
InTPP-loaded microspheres was not emitted by polymer.
Results and Discussion
Characterization of InTPP-loaded nanospheres and 
microspheres 
Figure 1 shows SEM images of the microspheres and 
nanospheres. It can be seen that for both formulations 
the shape of the particles was spherical with a large size 
distribution for microspheres (Figure 1a) and with a 
relatively homogenous size distribution for nanospheres 
(Figure 1b). No InTPP aggregates were detected in the 
particle samples.
Analysis of the SEM micrographs (Figure 1) by an 
imaging software showed that the microspheres were 
Figure 1. SEM images of: (a) microspheres and (b) nanospheres of 
InTPP-loaded PLGA prepared using an emulsion/evaporation method, 
employing PVA as an emulsifier, and with agitation rates of 1200 and 
14,000 rpm, respectively.
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obtained with a mean diameter of 1.9 ± 0.2 mm and with 
a size distribution ranging from 0.1 to 4.5 mm (Figure 2a). 
Nanospheres were obtained with a mean diameter of 
119 ± 9 nm, and a size distribution ranging from 25 to 
275 nm (Figure 2b). For the treatment of cancer or for the 
treatment of non-oncologic diseases the limit of particle size 
depends on the administration route and/or on the disease 
localization. For example, in intravenous administration, to 
circulate through the smallest capillaries the particle size 
should be less than 5 mm,24 but regardless of the transport 
mechanism, the pore cutoff size of several tumor models 
has been reported ranging between 380 and 780 nm.25 
Brain cancers are extremely difficult to treat due to a lack 
of therapeutic strategies capable of overcoming barriers 
for effective delivery of drugs to the brain. Considering the 
size of the endothelial gaps (300 nm), fenestrations (5.5 nm 
maximum width), cytoplasmic vesicles such as caveolae 
(50-70 nm diameter) and vesicular vacuolar organelles 
(108 nm diameter), the particle size necessary for brain 
treatment is less than 100 nm.26 Another example is for 
lung cancer treatment. The drug delivery systems can use 
the technique of inhaled aerosols but particle sizes in the 
1 to 5 mm range are necessary because these sizes allow 
particles to reach the lower airways and even the alveoli 
by gravitational sedimentation.27 For ocular administration, 
researchers have shown that the particle sizes should be in 
the 2 to 10 mm range to minimize irritation, to favor the 
rate and the extent of penetration into the aqueous humor 
and to reduce the quick clearance of the suspended particles 
from the conjuctival sac.28 Considering these facts, the size 
of nanospheres and microspheres obtained in this work is 
compatible with several models of drug administration that 
could be used in photodynamic therapy.
The percentage of recovered microspheres (90 ± 4 %) 
was 2.1 times higher than that obtained for nanospheres 
(43 ±  2%), due to the greater size of microspheres 
compared to the size of the nanospheres. The washing steps 
(experimental section) were repeated six times, always using 
centrifugation at 20,400 × g for a period of 20 min. There 
was a larger loss of particles (a mean loss of 57%) during 
this procedure for the formulation of nanospheres compared 
to the washing process of the formulation of microspheres 
(a mean loss of 10%). When a higher centrifugation rate and 
time were used (37,500 × g for a period of 40 min) to decrease 
the loss of particles in the formulation of nanospheres, there 
was only a small increase in the recovery yield the spheres, 
from 43% to 51%. Since the sedimentation rate of the 
particles in a centrifugal field is proportional to the square of 
the particle diameter, it should be expected that the recovery 
of microspheres after the washing process would be higher 
than the recovery of nanospheres. 
There was no significant difference in the entrapment 
efficiency of InTPP in the PLGA microspheres (91 ± 5%) or 
nanospheres (95 ± 3 %). Some researchers have attributed 
the low entrapment efficiency of hydrophobic drugs to an 
interaction between the drug and the surfactant used to 
stabilize the emulsion, producing a migration of the drug 
from the oil to the aqueous phase.29,30 The results from our 
work suggest that this problem does not occur for InTPP 
encapsulation in PLGA microspheres or nanospheres when 
PVA is used as an emulsifier, since the average entrapment 
efficiency of InTPP in both spheres was > 90%.
The mean percentage of residual PVA on the surface 
of the PLGA spheres was five times higher in the 
nanospheres (1.40 ± 0.20 %, m/m) than in the microspheres 
(0.28 ± 0.04%, m/m). This difference in concentration of 
PVA has been attributed by other researchers to differences 
in the particle size.12,18 A smaller particle size has a higher 
specific surface area (ratio of the surface area/volume) and 
therefore, requires a larger amount of PVA to stabilize the 
droplets in the emulsion. Thus, at the end of the preparation, 
these spheres retain a larger amount of adsorbed PVA on 
their surface.
The percentage of residual PVA present depends on 
the methodology used to prepare the PLGA spheres. 
Data in the literature indicates a considerable diversity. 
Figure 2. Size distribution of (a) microspheres and (b) nanospheres of 
InTPP-loaded PLGA, prepared using PVA as an emulsifier and agitation 
rates of 1200 and 14,000 rpm, respectively.
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For example, Konan et al.31 found a percentage between 
15.9% to 38.3% of residual PVA (M
w
 = 26,000 g mol-1) 
adsorbed on the surface of 50:50 PLGA nanospheres with 
a size of approximately 100 nm. Sahoo et al.12 found a 
lower value of (3.5± 0.3) % for the percentage of residual 
PVA (M
w
 = 30,000 to 70,000 g mol-1) for spheres having 
approximately the same size. Comparing these values 
with our results, it can be seen that the percentage of 
residual PVA was lower for the formulation prepared in 
our laboratory. It is likely that this result is associated with 
the washing procedure, or with the number of washings 
of the colloidal suspensions used to eliminate residual 
PVA.32 Konan et al.31 reported that excess PVA was 
eliminated using a filtration process. However, this process 
is not efficient for the elimination of PVA, and resulted 
in a higher percentage of residual PVA on the surface of 
their nanospheres.31 In the case of the results obtained 
by Sahoo et al.,12 the washing process used was similar 
to the process used in this work, although the number of 
washings employed (two) was less than that used in our 
work (six). Therefore, the increased number of washing 
steps decreased the residual PVA on the spheres,32 which 
is of particular interest for applications of the PLGA 
spheres, due to the nonbiodegradability of PVA. Konan 
et al.31 reported that the percentage of residual PVA on 
nanospheres loaded with meso-tetra(4-hydroxyphenyl)
porphyrin (p-THPP) was related to the affinity between the 
photosensitizer and the emulsifier molecules, which could 
induce the adsorption of PVA on the surface of the particle. 
We prepared nanospheres and microspheres unloaded with 
InTPP and the percentage of the residual PVA was the 
same as obtained for the micro and nanospheres loaded 
with InTPP. Considering this, we concluded that InTPP 
did not induce the adsorption of PVA on the surface of 
the particles. 
The zeta potential was negative for all spheres, but 
the zeta potential of the microspheres (–44.8 ± 1.3 mV) 
was 2.2 times more negative than that of the nanospheres 
(–20.0 ±  0.2 mV). In general, a highly negative zeta 
potential is expected for pure polyester spheres, owing 
to the presence of carboxyl groups at the extremities of 
the polymeric chains.33 Researchers have reported a clear 
differentiation of the zeta potential of noncoated PLGA 
spheres34 and those coated with PVA,12 with highly negative 
zeta potentials for noncoated spheres and less negative 
zeta potentials for coated spheres. Therefore, since the 
percentage of residual PVA is higher for nanospheres than 
for microspheres, it is likely that the degree of coating of 
the nanosphere surface was higher, and the zeta potential 
less negative, because of the decrease of uncapped carboxyl 
groups on the surface of the nanospheres.
Confocal microscopy
The distribution of the InTPP within PLGA microspheres 
was determined using confocal microscopy (Figure 3). The 
micrographs clearly show the fluorescence emitted by the 
InTPP encapsulated in the microspheres on excitation 
of the photosensitizer with an argon-krypton laser, since 
the fluorescence was derived from the microspheres, and 
no emission was observed from the regions outside the 
spheres. Spheres with no PLGA-entrapped InTPP were also 
analyzed as a control (not shown) and the absence of any 
emission confirmed that the fluorescence observed from 
the microspheres loaded with InTPP was due solely to the 
photosensitizer. Due to the magnification limitations of the 
microscope, it was not possible to observe the fluorescence 
emitted from the InTPP-encapsulated nanospheres. Optical 
cross sections obtained from the top of the microspheres, 
following a gradual increase of depth by 0.6 mm, confirmed 
the presence of InTPP inside the polymer matrix (Figure 3). 
The InTPP appeared to be homogenously distributed within 
the microspheres and no preferential distribution of InTPP 
towards the interior or towards the surface of the spheres 
was observed. In addition, the InTPP seemed to remain 
finely distributed, showing no evidence of large InTPP 
particles within the microspheres. 
In situ InTPP release
The organic solvent used as the release medium had no 
effect on the particle morphology. Microspheres maintained 
Figure 3. Confocal microscopic images of InTPP-loaded microspheres: 
(a) using differential interference contrast microscopy (DICM), (b) with 
excitation of InTPP using an argon laser, (c) overlapping of both former 
images, and (d) optical cross section taken from the top of the spheres 
(top row) with a gradual increase in depth of 0.6 mm.
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their spherical shape after 1384 h dispersed in isobutyl 
alcohol and no change was observed in the microsphere size 
(Figure 4). The same results were observed for nanospheres 
(data not shown). A diffuse reflectance accessory was also 
used to eliminate the interference of light scattering from 
spheres in the InTPP spectra as shown in Figure 5.
The InTPP absorbance spectra monitored without 
nanoparticle separation from the assayed medium (Figure 
6a) shows that the InTPP absorbance increased during 
the release experiments, suggesting that the InTPP was 
released from the PLGA nanospheres. Independent release 
experiments were carried out, at short, medium, and long 
times. For each case, the suspension was centrifuged and 
the absorbance of the supernatant was measured to identify 
if the InTPP absorbance could be attributed to the InTPP 
released into the isobutyl alcohol or if it was dispersed in 
the spheres (Figure 6b). The results showed that there was 
no difference between the profile or the intensity of the 
absorbance spectrum of InTPP from a centrifuged sample 
(supernatant) and a noncentrifuged sample (suspension), 
suggesting that the InTPP spectra measured without 
separation of the nanospheres from the release medium 
belongs to InTPP released into the isobutyl alcohol and 
not to InTPP dispersed in the nanospheres. This hypothesis 
was corroborated by quantification of the released InTPP 
in the isobutyl alcohol and of the residual InTPP in the 
centrifuged nanospheres for each experiment performed at 
short, medium and long release times. The values obtained 
for the released and for the residual InTPP were 0.5 mg 
and 3.1 mg for the release time of 1.5 h, 2.0 mg and 1.6 mg 
after 78.3 h, and 3.1 mg and 0.3 mg at 483.5 h, respectively. 
The amount of InTPP released in the isobutyl alcohol 
increased from 0.5 mg to 3.1 mg when the independent 
experiments were performed at 1.5 h and 483.5 h and the 
residual InTPP determined in the spheres decreased from 
3.1 mg to 0.3 mg. These results corroborated the capacity 
of this new technique to monitor the release of InTPP in 
the isobutyl alcohol without particles separation from the 
release medium. 
Figure 7 shows the release profiles of InTPP from the 
PLGA microspheres and nanospheres in the form of the 
percentage of InTPP released with time. The released 
InTPP was monitored over a period of about 1400 h for 
the microspheres and 500 h for the nanospheres. Recent 
work showed that three different mechanisms govern drug 
release from PLGA nanoparticles in an aqueous medium.35 
The mechanisms consist of an initial burst release, a 
degradative relaxation-induced drug dissolution release and 
Figure 4. SEM images of microspheres of InTPP-loaded PLGA (a) before 
and (b) after 1384 h dispersed in isobutyl alcohol at 27 oC.
Figure 5. Absorbance spectra of an InTPP-loaded nanoparticle suspension 
in isobutyl alcohol at 27 oC obtained (―) with and (---) without the diffuse 
reflectance accessory. The total InTPP concentration in the suspension 
was 2.0 mmol L-1.
Figure 6. Absorbance spectra of InTPP (Soret Band): (a) measured 
without nanosphere separation from isobutyl alcohol during the release 
time, and (b) measured before and after nanoparticle separation from the 
release medium by centrifugation in short, medium and long release times.
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finally a diffusional release. In this situation, degradative 
relaxation plays an important role to create the free volume 
lacking in the initially glassy PLGA matrix and promotes 
additional release. Therefore, polymeric matrix degradation 
accelerates drug release and this is faster than that observed 
in our results because the isobutyl alcohol did not provoke 
the polymeric matrix degradation. Literature results have 
shown that the release of the encapsulated drug into an 
aqueous medium can reach 60 % to 100 % 24 h after 
its administration.36 But our results obtained in isobutyl 
alcohol indicate the InTPP released from microspheres 
and nanospheres reached 30 and 40% after the same 
release time, respectively. Recently, we showed that only 
two hours of incubation were sufficient for InTPP-loaded 
PLGA nanospheres to reduce the viability of LNCaP 
prostate tumor cells.7 
The results shown in Figure 7 indicate that the release 
of InTPP was characteristically biphasic, with an initial 
fast release, followed by a second slower release. This 
biphasic characteristic is an interesting property for clinical 
application of encapsulated InTPP because it allows the 
irradiation to be performed after short or longer intervals 
after administration of photosensitizer without needing 
a new dose of the drug. Results reported in the literature 
have shown that short intervals are typical for skin cancer 
treatment and longer intervals for lung, prostate and brain 
cancer treatment.37 In the initial “burst” phase, around 19% 
of the InTPP was released from the nanospheres within the 
initial 6 h, while around 28% of the InTPP was released 
from the microspheres within the first 2.2 h. This initial 
rapid release was attributed to the InTPP in the superficial 
zone, i.e., that adsorbed on the particle surface or dispersed 
in the particle very close to its surface. The residual 
percentage of PVA on the surface of the nanospheres was 
five times higher than for the surface of the microspheres. 
Researchers have shown that the large amounts of residual 
PVA present on the particle surface form a barrier to drug 
release.12 Hence, it is possible that the larger amount of PVA 
present on the surface of nanospheres hampered the release 
of InTPP located in the superficial zone of a nanosphere, 
leading to a decrease in the rate of InTPP release. 
The second, slower release phase was attributed to 
diffusion of dissolved InTPP into the release medium from 
within the PLGA core of the spheres, since no surface 
degradation of the particle was observed in SEM analysis, 
even after long release times (Figure 4). Figure 7 shows 
that 94% of the InTPP was released from the nanospheres 
after 484 h, while 75% of the InTPP was released from 
the microspheres after 1385 h. This difference is expected, 
because the increased size of the microspheres means 
that the diffusion path length is increased and, thus, the 
concentration gradient and mass transport rate is decreased. 
Moreover, larger spheres have a smaller specific surface 
area (surface area : volume), allowing a more delayed 
release of the drug in the second release phase.11 The 
release profile from microspheres loaded with InTPP was 
characterized by multiple increases and decreases in the 
release rate. The irregular release from microspheres can 
be explained as a weighted combination of the release 
profiles, resulting from the various sizes of the microspheres 
in the sample (Figure 2a). Berkland et al.11 have also 
reported an irregular release profile due to nonuniform 
microsphere size. The same behavior was not observed 
for the nanospheres since the smaller distribution of the 
spheres favors a more regular release rate. 
Mathematical model applied to the release profiles
Fitting equation (5) to the experimentally determined 
InTPP release rate from the InTPP-loaded PLGA 
nanospheres led to a good agreement between Jo’s diffusion 
model and the experimental data (Figure 8a, solid curve) 
since the correlation coefficient was R2 = 0.9886. However, 
the same result was not obtained for InTPP released from 
the microspheres (Figure 8b, solid curve) since R2 = 0.5503. 
This outcome suggests that the release of InTPP from the 
Figure 7. Release profiles of InTPP-loaded PLGA: (a) nanospheres and 
(b) microspheres in isobutyl alcohol at 27 °C.
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nanospheres was controlled by diffusion, while the release 
of InTPP from the microspheres was influenced by both the 
diffusion from the interior and the nonuniform size of the 
spheres. The latter contributed to an irregular release profile 
that hampered the fitting of equation (5). It is expected that, 
for a substance homogeneously dispersed within spheres, 
any release would occur mainly by diffusion through 
the polymer matrix.38 The value of D, obtained from the 
nonlinear fitting of the curve, was 2.4 × 10–21 m2 s-1 and 
5.3 × 10–14 m2 s-1 for the InTPP released from the nanospheres 
and the microspheres, respectively. Diffusion coefficients 
of drugs in organic phases are usually of the order of 
10–9 m2 s-1,39 so the observed coefficients were clearly 
lower than expected. Thus, the low values of the diffusion 
coefficients for InTPP encapsulated in microspheres and 
in nanospheres suggest that the InTPP was retained by the 
matrix of the spheres. This was corroborated by confocal 
microscopy (Figure 3) since the micrographs of optical 
cross sections confirmed that the InTPP was inside the 
polymeric matrix.
 
On fitting curves to the data from this work using equation 
(7), a somewhat better agreement was obtained between 
Peppas’s empirical model and the experimental data for 
InTPP released from the nanospheres (Figure 8a, dot-dash 
curve) than for InTPP released from the microspheres 
(Figure 8b, dot-dash curve), since R2 = 0.9876 for the InTPP 
release from the nanospheres and R2 = 0.9406 for InTPP 
release from the microspheres. A value of n = 0.44 ± 0.01, 
obtained for the release of InTPP from the nanospheres, 
indicates that this release was governed by Fickian diffusion. 
This result is similar to that obtained using Jo’s mathematical 
model.20 The value of n = 0.23 ± 0.01 for release from the 
microspheres shows that this release is not governed by 
Fickian diffusion. This conclusion also agrees with the results 
obtained from Jo’s diffusion model. The undefined release 
mechanism of the InTPP encapsulated in microspheres was 
related to the nonuniform size of the spheres that caused an 
irregular release rate of the InTPP and hampered the fit of 
mathematical models to the release profile. 
The experimental data better fit Polakovic’s dissolution 
model for InTPP release from the nanospheres (Figure 8a, 
dashed curve) than for InTPP release from microspheres 
(Figure 8b, dashed curve) since R2 = 0.9495 and 0.1448, 
respectively. However, these results suggest that the 
release of InTPP from either the nanospheres or the 
microspheres was not controlled by InTPP dissolution, 
since the fits using Jo’s and Peppas’s diffusion models 
was better than that using Polakovic’s dissolution 
model. The lack of fit to Polakovic’s dissolution model 
agrees with the confocal micrographs that showed no 
evidence of large InTPP aggregates within the spheres. 
The apparent dissolution rate constants for the release 
of InTPP from the nanospheres or microspheres were 
4.5 × 10–6 s–1 and 6.9 × 10–7 s–1, respectively. Polakovic 
et al.23 showed that diffusion through a polymer matrix 
was the best mathematical model to use to fit the release 
kinetics of lidocaine from PLA nanospheres with low 
drug loadings (< 10 % w/w), and the dissolution model 
was more suitable to describe the release from spheres 
with higher drug loadings (> 10 %). Similar observations 
were obtained by Gorner et al.,40 who presumed the 
formation of a homogeneous matrix with the drug being 
randomly distributed throughout the polymer particles 
at low loading, with a heterogeneous matrix existing at 
high loadings. These literature data, in association with 
confocal microscopy and the results of the mathematical 
models applied to the release profiles, lead us to suggest 
that the InTPP was distributed homogeneously in the 
polymer matrix. Since the percentage of InTPP loading 
in the PLGA spheres was < 1% (0.56 ± 0.02 %, m/m), 
no evidence of large InTPP aggregates within the spheres 
was observed and both Fickian models (Jo’s and Peppas 
models) were better fitted to the release profiles than was 
Polakovic’s dissolution model, 
Figure 8. Fit of the mathematical diffusion model to the experimentally 
determined InTPP release rate from InTPP-loaded PLGA: (a) nanospheres 
and (b) microspheres using isobutyl alcohol at 27 °C.
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Conclusions
The elimination of the interference of light scattering 
from spheres in the InTPP absorbance spectra, by use of a 
diffuse reflectance accessory allows in situ monitoring of 
the release of the encapsulated InTPP. This new technique 
reduces the necessity of centrifugation steps to quantify 
the InTPP released in defined intervals of time. The release 
profiles from InTPP-loaded microspheres and nanospheres 
were characterized by a burst phase complemented by a 
second slower release phase. The rapid release phase was 
attributed to InTPP in the superficial zone of the particles. 
Nanospheres delayed the InTPP release in the burst phase due 
to the large percentage of PVA on their surface. However, the 
microspheres presented a slower release rate for the second 
phase due to the increase of the diffusion path length and the 
reduced specific surface area. Mathematical models applied 
to the release profiles allowed concluding that the release of 
InTPP from nanospheres was controlled by diffusion, which 
is to be expected for a substance homogeneously dispersed 
within the spheres. However, due to the large size distribution 
of the microspheres loaded with InTPP, the release profiles 
were irregular, hampering an adequate fit to our mathematical 
models. Confocal microscopy data from different optical 
cross sections showed that the InTPP distribution was 
homogeneous in microspheres with no evidence of InTPP 
aggregation being present. 
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